Sevion Therapeutics, Inc. (SVON) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Sevion Therapeutics, Inc. (SVON) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sevion Therapeutics, Inc. (SVON) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Sevion Therapeutics, Inc. (SVON) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
39 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Sevion Therapeutics, Inc. (Sevion), formerly Senesco Technologies, Inc. is a pharmaceutical company that discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company has developed protein nanocage system that allows delivery of nucleic acids and other payloads to target cells. Its product pipeline includes SVN-00, SVN-002, SVN-003, multiple GPCR targets and ion channel. The companys SVN-002 is an antibody against an oncology target that has the potential to impact metastatic tumors, which include resistant to anti-VEGF treatments. Sevion is headquartered in San Diego, California, the US.

Sevion Therapeutics, Inc. (SVON) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- De

  
Source:
Document ID
GDPH81797D
Country
Industry
Ticker
SVON=US
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Sevion Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Sevion Therapeutics, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Sevion Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Sevion Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Sevion Therapeutics, Inc., Medical Devices Deals, 2010 to YTD 201691
Sevion Therapeutics, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
Sevion Therapeutics, Inc., Pharmaceuticals &Healthcare, Deal Details1224
  Venture Financing121
    Fabrus Secures US$2 Million In Venture Financing121
  Partnerships131
    Tetragenetics Enters into Agreement with arGEN-X, Crystal Biosciences and Sevion Therapeutics132
    Sevion Therapeutics to Form Joint Venture with Malvern Instruments151
    Sevion Therapeutics Enters into Discovery Agreement with CNA Development161
    Sevion Therapeutics Enters into Research Agreement with Avidity NanoMedicines171
    Fabrus Enters Into Research Agreement With Ambrx181
  Licensing Agreements191
    Fabrus Enters into Licensing Agreement with Scripps Research Institute191
  Equity Offering201
    Sevion Therapeutics Raises USD6.6 Million in Private Placement of Units202
    Senesco Raises USD3.5 Million in Private Placement of Shares upon Exercise of Warrants221
    Senesco Raises USD5.4 Million in First Tranche of Private Placement of Units231
    Senesco Technologies Completes Private Placement Of Shares For US$1.7 Million241
    Senesco Technologies Completes Private Placement Of Shares For US$1.25 Million252
    Senesco Technologies Completes Private Placement Of Shares For US$3 Million272
    Senesco Technologies Completes Second Tranche Of Private Placement Of Shares For US$1 Million292
    Senesco Technologies Completes Second Tranche Of Private Placement For US$1.65 Million311
    Senesco Technologies Completes Private Placement Of US$11.5 Million322
  Acquisition341
    Senesco Technologies Completes Acquisition of Fabrus342
Sevion Therapeutics, Inc. - Key Competitors361
Key Employees371
Locations And Subsidiaries381
  Head Office381
  Other Locations &Subsidiaries381
Appendix391
  Methodology391
  About GlobalData391
  Contact Us391
  Disclaimer391

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Sevion Therapeutics, Inc. (SVON) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sevion-Therapeutics-Inc-SVON-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7605>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Sevion Therapeutics, Inc. (SVON) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Sevion-Therapeutics-Inc-SVON-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7605>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research